Homologous desensitization insulinotropic glucagon-like peptide-I receptor insulinoma cells Glucagon-like peptide-I GLP-I intestinal peptide potent insulinotropic activities pancreatic beta-cells vivo vitro studies concentrations GLP-I insulin release cAMP generation beta-cells GLP-I receptor glucose-responsive B-cell line undergoes rapid reversible homologous desensitization response supraphysiological concentrations GLP-I GLP-I insulin release cAMP generation glucose-dependent biphasic manner maximum stimulation nmol/liter first-phase insulin secretory response doses GLP-I nmol/liter Preperifusion B-cells nmol/liter GLP-I min subsequent insulin secretory response nmol/liter GLP-I hormone washout recovery periods min reduction min reduction full recovery Preperifusion cells nmol/liter glucagon min nmol/liter gastric inhibitory peptide GIP min effect insulin secretory response nmol/liter GLP- Prior exposure cells nmol/liter GLP- min GIP-induced nmol/liter insulin release nmol/liter GIP min insulin secretion stimulation nmol/liter GIP data GLP-I receptor subject rapid reversible homologous desensitization GLP-I receptor beta-cells distinct GIP recent finding GLP-I amide levels subjects noninsulin-dependent diabetes possibility homologous desensitization GLP-I receptor impaired insulin secretion disorder 